CL
BNR

CRCM LP’s Burning Rock Biotech BNR Stock Holding History

CRCM LP’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Sell
211,997
-70,100
-25% -$993K 1.17% 9
2026
Q1 		$4.6M Sell
282,097
-209,329
-43% -$5.48M 3.26% 4
2025
Q4 		$9.9M Buy
491,426
+269,851
+122% +$3.94M 3.35% 7
2025
Q3 		$1.92M Buy
221,575
+26,809
+14% +$192K 0.55% 10
2025
Q2 		$615K Sell
194,766
-31,524
-14% -$97.8K 0.18% 9
2025
Q1 		$1.02M Sell
226,290
-99,679
-31% -$622K 0.42% 5
2024
Q4 		$2.2M Buy
+325,969
New +$1.5M 0.89% 5

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return

CRCM LP's BNR Position: Q2 2026 in Review

CRCM LP reduced its Burning Rock Biotech (BNR) stake by 25% in Q2 2026, selling an estimated $993K and leaving 211,997 shares worth $1.77M. The position accounts for 1.17% of the portfolio, ranked #9.

CRCM LP first reported a position in BNR in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.9M in Q4 2025. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • CRCM LP held 211,997 shares of Burning Rock Biotech worth $1.77M as of Q2 2026.
  • CRCM LP sold 70,100 Burning Rock Biotech shares in Q2 2026, an estimated $993K.
  • Burning Rock Biotech made up 1.17% of CRCM LP's portfolio in Q2 2026, its #9 holding.
  • CRCM LP first reported a position in Burning Rock Biotech in Q4 2024 and has held it in 7 quarters since.
  • CRCM LP's Burning Rock Biotech position peaked at $9.9M in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on CRCM LP's 13F filing for Q2 2026, filed 12 Aug 2026.